Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study

There are limited real-world data on the use of botulinum toxin type A (BoNT-A) in patients with multiple sclerosis (MS). Accordingly, this nationwide, population-based, retrospective cohort study aimed to describe BoNT-A treatment trends in patients with MS between 2014 and 2020 in France. This stu...

Full description

Bibliographic Details
Main Authors:	Djamel Bensmail, Pierre Karam, Anne Forestier, Jean-Yves Loze, Jonathan Lévy
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Toxins
Subjects:	botulinum toxin France multiple sclerosis spasticity neurogenic detrusor overactivity
Online Access:	https://www.mdpi.com/2072-6651/15/4/280

Similar Items

Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France
by: Jonathan Levy, et al.
Published: (2023-08-01)

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Botulinum toxin injection: a review of injection principles and protocols
by: David E. Rapp, et al.
Published: (2007-04-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

Therapeutic Approaches of Botulinum Toxin in Gynecology
by: Marius Alexandru Moga, et al.
Published: (2018-04-01)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
by: Shang-Jun Wu, et al.
Published: (2019-01-01)

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature
by: David C. Moore, et al.
Published: (2016-03-01)

Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study
by: Ines Baccouche, et al.
Published: (2022-08-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
by: Fan-Ching Hung, et al.
Published: (2022-12-01)

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
by: Cheng-Ling Lee, et al.
Published: (2022-01-01)

FREQUENCY OF DETRUSOR LEAK POINT PRESSURES AMONGST PATIENTS WITH URODYNAMIC DIAGNOSIS OF DETRUSOR OVERACTIVITY
by: Nadeem Ahmad, et al.
Published: (2019-08-01)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
by: Federica Novarella, et al.
Published: (2022-11-01)

Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice
by: R. K. Shikhkerimov, et al.
Published: (2022-12-01)

BOTULINUM IN MODERN UROLOGY
by: A. D. KAPRIN, et al.
Published: (2016-12-01)

A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus
by: Gerard E. Francisco, et al.
Published: (2021-01-01)

Use of botulinum toxin in children with cerebral palsy
by: Monika Stecko, et al.
Published: (2019-07-01)

Use of botulinum toxin in children with cerebral palsy
by: Monika Stecko, et al.
Published: (2019-07-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

The Evaluation of Botulinum Toxin Injection Effect for Poststroke Spasticity Treatment
by: Bekir Enes Demiryurek, et al.
Published: (2017-03-01)

Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
by: Shu-Yu Wu, et al.
Published: (2021-06-01)

A Review of the Efficacy of Botulinum Toxin in Spasticity Reduction in Upper and Lower Extremities and Gait improvement in Individuals with Stroke
by: Saede Shahriarpour, et al.
Published: (2016-03-01)

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
by: S. Deffontaines-Rufin, et al.
Published: (2011-10-01)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01)

The Efficacy of Botulinum Toxin A Intramuscular Injections in After-Stroke Spasticity
by: Melek Karaçam, et al.
Published: (2010-09-01)

The Efficacy of Botulinum Toxin A Intramuscular Injections in After-Stroke Spasticity
by: Melek Karaçam, et al.
Published: (2010-09-01)

Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery
by: Hsiang-Ying Lee, et al.
Published: (2023-03-01)

A literature review on the efficacy and safety of botulinum toxin: An injection in post-stroke spasticity
by: Majid Ghasemi, et al.
Published: (2013-01-01)

Perioperative Techniques for the Use of Botulinum Toxin in Overactive Bladder: Results of a Multinational Online Survey of Urogynecologists in Germany, Austria, and Switzerland
by: Sören Lange, et al.
Published: (2023-02-01)

Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies
by: Riccardo Bientinesi, et al.
Published: (2020-06-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01)

The role of Botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery
by: Shome Debraj, et al.
Published: (2007-01-01)

Analysis of the effects of the upper limb improvement programme in patients after ischemic stroke treated with botulinum toxin
by: Elżbieta Mirek, et al.
Published: (2017-12-01)

Hyperactive bladder: concept of disease and paradigms in the treatment
by: G. G. Krivoborodov, et al.
Published: (2021-04-01)